Patient Square Capital
Overview
Patient Square Capital is a dedicated health care investment firm that partners with management teams whose products, services, and technologies improve health. The firm aims to achieve strong investment returns by collaborating with high-quality, growth-oriented companies and top-tier management teams. Patient Square utilizes deep industry expertise, a broad network of relationships, and a partnership approach to make investments in companies that strive to improve patient lives, strengthen communities, and create a healthier world.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nuclera Nucleics | Jan 2026 | Series C | Co-investor |
| Kriya Therapeutics | Sep 2025 | Series D | Lead |
| ChenMed | May 2025 | Private Equity | Co-investor |
| Patterson Companies, Inc. | Apr 2025 | Take Private | Lead |
| LXE Hearing | Mar 2025 | Corporate Funding | Lead |
Key People
Adam Fliss
Founding Partner And General Counsel
Neel Varshney
Founding Partner
Kaveh Samie
Partner, Chairman And CEO Of MENA And Head Of International Fund Partnerships
Jim Momtazee
Managing Partner
Rebecca Marty
EA To Managing Partner
David Katz
Partner
Emily Janvey
Partner, Co-Head Of Royalty And Structured Solutions
Laura Furmanski
Partner And Head Of Patient Square Insights
Russell Chong
Partner
Patrick Martin
Principal
Brendan Wu
Investor
Eric Jincai Zhang
Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
